Press Release

Viral Vector Manufacturing Market Surges with the Growing Demand for Gene Therapy & Vaccine Development

The Global Viral Vector Manufacturing Market is projected to grow at a CAGR of around 19.22% during the forecast period of 2024-30, cites MarkNtel Advisors in the recent research report. In recent years, there has been a notable surge in the prevalence of genetic disorders, notably hemophilia, across the globe, specifically in countries like the US, India, etc. This escalation in hemophilia cases has caused an increased demand for gene therapy as a treatment modality, consequently driving the need for viral vectors essential in facilitating gene therapy delivery. Moreover, the rising incidence of other genetic blood disorders, such as sickle-cell disease and thalassemia, further contributes to the burgeoning demand for viral vectors.

Simultaneously, the mounting incidence of various cancer types, including Non-Hodgkin lymphoma and leukemia, has prompted a heightened need for improved cancer treatments. Given the limitations and adverse effects associated with conventional therapies like chemotherapy, there is a notable shift towards exploring the potential of cancer gene therapy and cell therapy treatments. This burgeoning demand for gene and cell therapy resulted in an increased need for viral vectors, which has been an integral component in these therapeutic approaches, thereby driving growth in the Global Viral Vector Manufacturing market.

Furthermore, the initiation of clinical trials for novel gene therapies underscores the escalating investment in gene therapy research and development. As these clinical trials expand globally, there would be a corresponding surge in demand for viral vectors to support these endeavors. With more gene therapies advancing into clinical trials to address rare diseases, the demand for viral vectors is poised to witness significant growth, propelling the market forward, further states the research report, “Global Viral Vector Manufacturing Market Analysis, 2024.”

 Global Viral Vector Manufacturing Market Segmentation Analysis

Adenoviral Vector Segment Dominated the Global Viral Vector Manufacturing Market

Based on the vector type segment, the market is further segmented into Adenoviral Vector, Adeno-Associated Viral Vector, Lentiviral Vector, Herpes Simplex Viral Vector, Retroviral Vector, and Others. Of all the segments, the Adenoviral Vector segment emerged to be a dominant segment with a significant share of the market. Renowned for their efficacy, safety, and scalability, adenoviral vectors have emerged as favored platforms for various therapeutic applications, including gene therapy and vaccine development. The surge in patients grappling with genetic disorders like hemophilia and thalassemia has further catalyzed the demand for gene therapies, consequently amplifying the need for adenoviral vectors renowned for their high efficiency in gene delivery.

North America Witnessed Considerable Growth in the Global Viral Vector Manufacturing Market

The Global Viral Vector Manufacturing Market has been dominated by North America, boasting the largest share attributed to a confluence of factors. Among these, the burgeoning population with genetic disorders, coupled with the presence of key industry players have emerged as prominent factors. North America has been harboring a substantial patient pool with genetic disorders. Thus, the need to combat complex genetic disorders accelerated the demand for viral vectors, serving as pivotal components in the delivery of gene therapies.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market players, including Oxford Biomedica PLC, Charles River Laboratories, FUJIFILM Corporation, Lonza, Merck KgaA, Catalent, Inc., AGC Biologics, Thermo Fisher Scientific Inc., Vector BioMed, Biovian Oy, ReiThera srl, Curia Global, Inc., Aurigene Pharmaceutical Services Ltd., Revvity, etc., are looking forward to strengthening their market position.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the Global Viral Vector Manufacturing Market?
3. What key factors would propel and impede the industry across the globe?
4. How has the industry been evolving in terms of geography & service adoption?
5. How has the competition been shaping across various regions?
6. How has the buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2019-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?